Skip to content

ALDEYRA THERAPEUTICS, INC.: 10-Q filed 2020-11-05

What ALDEYRA THERAPEUTICS, INC. reported in its quarterly report filed 2020-11-05 (fiscal Q3 2020): 34 published measures, 85 facts as tagged in accession 0001564590-20-051290.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-05
Fiscal period
fiscal Q3 2020
Accession
0001564590-20-051290 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALDEYRA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3088,324,430USD
At 2019-12-3175,518,281USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-3019,153,983USD
At 2019-12-3127,435,964USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-3069,170,447USD
At 2020-06-3052,789,666USD
At 2019-12-3148,082,317USD
At 2019-09-3050,879,294USD
At 2019-06-3067,333,370USD
At 2018-12-3186,617,979USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3086,175,507USD
At 2019-12-3144,425,830USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-8,873,173USD92
2020-01-01 to 2020-09-30-26,261,549USD274
2019-07-01 to 2019-09-30-18,715,014USD92
2019-01-01 to 2019-09-30-47,666,208USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-29,176,258USD274
2019-01-01 to 2019-09-30-33,757,903USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-309,529USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-3041,902,025USD274
2019-01-01 to 2019-09-3015,242,627USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-3029,023,910USD274
2019-01-01 to 2019-09-3022,762,007USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-225,623,548USD
At 2019-12-31-199,361,999USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-1,309,973USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-3079,455USD
At 2019-12-31148,449USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-305,453,520USD274
2019-01-01 to 2019-09-306,133,990USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-8,389,197USD92
2020-01-01 to 2020-09-30-25,133,519USD274
2019-07-01 to 2019-09-30-19,016,189USD92
2019-01-01 to 2019-09-30-50,178,793USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3088,192,780USD
At 2019-12-3175,168,825USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-30489,191USD92
2020-01-01 to 2020-09-301,415,055USD274
2019-07-01 to 2019-09-3029,154USD92
2019-01-01 to 2019-09-3059,766USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-306,460,672USD
At 2019-12-3112,907,752USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-30123,900USD
At 2019-12-31808,302USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-306,133,580USD92
2020-01-01 to 2020-09-3017,653,058USD274
2019-07-01 to 2019-09-3016,223,972USD92
2019-01-01 to 2019-09-3034,737,420USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3038,631,709shares
At 2019-12-3128,656,832shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-09-3086,175,507USD
At 2019-12-3144,425,830USD
At 2019-09-3051,604,203USD
At 2018-12-3147,357,472USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-12-315,866USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-3052,195USD
At 2019-12-31201,007USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-3058,720USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2019-12-3116,042,500USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-304,018,635USD
At 2019-12-3111,873,122USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-302,017,273USD
At 2019-12-311,804,450USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-8,873,173USD92
2020-01-01 to 2020-09-30-26,261,549USD274
2019-07-01 to 2019-09-30-18,715,014USD92
2019-01-01 to 2019-09-30-48,976,181USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-26,261,549USD274
2019-01-01 to 2019-09-30-47,666,208USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-8,877,927USD92
2020-01-01 to 2020-09-30-26,267,415USD274
2019-07-01 to 2019-09-30-18,722,701USD92
2019-01-01 to 2019-09-30-47,651,218USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,255,617USD92
2020-01-01 to 2020-09-307,480,461USD274
2019-07-01 to 2019-09-302,839,319USD92
2019-01-01 to 2019-09-308,940,771USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-483,976USD92
2020-01-01 to 2020-09-30-1,128,030USD274
2019-07-01 to 2019-09-30301,175USD92
2019-01-01 to 2019-09-301,202,612USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-09-3040,716,543USD274
2019-01-01 to 2019-09-30720,964USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-684,402USD274
2019-01-01 to 2019-09-30-3,082,081USD273

Inspect the source

Entity
ALDEYRA THERAPEUTICS, INC. / CIK 0001341235
Captured
2026-09-20T07:54:15.451Z
SEC response SHA-256
71cda24b59474759e40949f545ab949ecdfc2871814e3cf45050931d1c516763

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001341235.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))